Research Papers:
TAK1 inhibitor 5Z-7-oxozeaenol sensitizes cervical cancer to doxorubicin-induced apoptosis
Metrics: PDF 2814 views | HTML 3550 views | ?
Abstract
Shan Guan1,2, Jiaxiong Lu2, Yanling Zhao2, Sarah E. Woodfield3, Huiyuan Zhang2, Xin Xu2, Yang Yu2, Jing Zhao1, Shayahati Bieerkehazhi4, Haoqian Liang2,5, Jianhua Yang2, Fuchun Zhang1, Surong Sun1
1Xinjiang Key Laboratory of Biological Resources and Genetic Engineering, College of Life Science and Technology, Xinjiang University, Urumqi, Xinjiang 830046, China
2Texas Children’s Cancer Center, Department of Pediatrics, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
3Division of Pediatric Surgery, Michael E. DeBakey Department of Surgery, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA
4Department of Labour Hygiene and Sanitary Science, College of Public Health, Xinjiang Medical University, Urumqi, Xinjiang 830011, China
5School of Pharmacy, Zhengzhou University, Zhengzhou, Henan 450001, China
Correspondence to:
Surong Sun, email: [email protected]
Fuchun Zhang, email: [email protected]
Keywords: cervical cancer, TAK1 inhibitor, 5Z-7-oxozeaenol, chemotherapy, doxorubicin
Received: February 22, 2017 Accepted: March 28, 2017 Published: April 06, 2017
ABSTRACT
Aberrant activation of nuclear factor-κB (NF-κB) allows cancer cells to escape chemotherapy-induced cell death and acts as one of the major mechanisms of acquired chemoresistance in cervical cancer. TAK1, a crucial mediator that upregulates NF-κB activation in response to cellular genotoxic stress, is required for tumor cell viability and survival. Herein, we examined whether TAK1 inhibition is a potential therapeutic strategy for treating cervical cancer. We found that TAK1 inhibitor 5Z-7-oxozeaenol significantly augmented the cytotoxic effects of Dox in a panel of cervical cancer cell lines. Treatment with 5Z-7-oxozeaenol hindered Dox-induced NF-κB activation and promoted Dox-induced apoptosis in cervical cancer cells. Moreover, 5Z-7-oxozeaenol showed similar effects in both positive and negative human papillomavirus-infected cervical cancer cells. Taken together, our results provide evidence that TAK1 inhibition significantly sensitizes cervical cancer cells to chemotherapy-induced cell death and supports the use of TAK1 inhibitor with current chemotherapies in the clinic for patients with refractory cervical cancer.
![Creative Commons License](/images/80x15.png)
PII: 16895